SCHEMBL14449261

SCHEMBL14449261

CCOC(=O)/C=C/c1sc2ccc(C(F)(F)F)cc2c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.40
ESR1 P03372 2/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
MLYCD O95822 1/20 0.40
TTR P02766 1/20 0.40
DPP4 P27487 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CYP3A4 P08684 1/20 0.38
HTT P42858 1/20 0.38
HSD17B1 P14061 1/20 0.38
HSD17B2 P37059 1/20 0.38
MAOB P27338 1/20 0.37
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4654254 0.84 ESR1 (0.42) ESR1HTTMEN1KMT2A
SCHEMBL4654250 0.84 ESR1 (0.42) ESR1HTTMEN1KMT2A
SCHEMBL14016166 0.82 ESR1 (0.40) MAPTESR1LMNATP53MLYCD
SCHEMBL6963324 0.81 ALDH1A1 (0.45) MAPTESR1TTRDPP4CA12
SCHEMBL6963319 0.81 ALDH1A1 (0.45) MAPTESR1TTRDPP4CA12
SCHEMBL4654112 0.78 MEN1 (0.38) MEN1KMT2A
SCHEMBL4654108 0.78 MEN1 (0.38) MEN1KMT2A
SCHEMBL3683576 0.77 LMNA (0.53) MAPTLMNATP53NPSR1MEN1
SCHEMBL10748661 0.76 ALDH1A1 (0.45) MAPTESR1LMNATTRNPSR1
SCHEMBL10748656 0.76 ALDH1A1 (0.45) MAPTESR1LMNATTRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease ABAT, BPTF, TNNT2 MAPT 1081/4885ESR1 2254/4885LMNA 1736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.